To the Honorable Chiquita Brooks-LaSure
Centers for Medicare & Medicaid Services
As the sponsors of the Treat and Reduce Obesity Act (H.R. 1577/S. 596), we write to urge you to use your regulatory authority to give seniors access to Food & Drug Administration (FDA) approved anti-obesity medications (AOMs) and to improve access to Intensive Behavioral Therapy (IBT) for obesity. We are hopeful that CMS will not only recognize the devastating impact that COVID-19 is having on the health outcomes of so many Americans living with obesity, but also the disproportionate toll obesity is having on communities of color. As such, we hope that CMS will use its resources to update Medicare's coverage policies to provide comprehensive coverage for effective therapies to treat obesity.